Executive Summary
The Global Gene and Cell Therapy (GCT) Market is estimated at USD 2504.2 Million in the year 2020. Growth in the historic period in the cell and gene therapy market resulted from increase in investments in cell and gene therapies, growth in research and development, advances in cancer drug discovery, rise in public-private partnerships, strong economic growth in emerging markets, increased healthcare expenditure, and rising in pharmaceutical R&D expenditure.
Companies in the gene and cell therapy for oncology market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, organizations are developing innovative products as well as sharing skills and expertise with other such enterprises. While oncology drug companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, in or out licensing deals, this trend has been increasing over the recent years.
Further, the market was restrained by inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centers. Going forward, increasing prevalence of cancer and chronic diseases, rising geriatric population, rising focus on cell and gene therapy, and rise in healthcare expenditure will drive the growth in the gene and cell therapy market. Factors that could hinder the growth of the market in the future include high costs of therapy, stringent regulations, reimbursement challenges, and coronavirus pandemic.
Scope of the Report
- The report presents the analysis of Gene and Cell Therapy market for the historical period 2016-2020 and forecast period of 2021-2026.
- The report analyses the Gene and Cell Therapy Market by value (USD Million).
- The report analyses the Gene and Cell Therapy Market by Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others).
- The report analyses the Gene and Cell Therapy Market Application (Oncology, Neurological disorders, cardiovascular disorders, Others).
- The Global Gene and Cell Therapy Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA), By Country (United States, Canada, Germany, U.K, France, Italy, China, Japan, India and South Korea).
- The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Vector, By Application.
- Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include F. Hoffman-La Roche Ltd., Novartis, Sanofi, Alnylam Pharmaceuticals Inc., Pfizer, BlueBird Inc., Sarepta Therapeutics, Voyager Therapeutics, Orchard Therapeutics Plc, AnGes Inc.
Key Target Audience
- Biotechnology Companies
- Pharmaceutical and Health Companies
- Consulting and Advisory Firms
- Government and Policy Makers
- Regulatory Authorities
Global Gene and Cell Therapy (GCT) Market - Analysis By Vector, Application, By Region, By Country (2021 Edition): Market Insights, Pipeline, Forecast with Impact of COVID-19 (2021-2026)
Table of Contents
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Gene and Cell Therapy Market: Product Outlook
4. Global Gene and Cell Therapy Market: Sizing and Forecast
4.1 Global Gene and Cell Therapy Market Size, By Value, Year 2016-2026
5. Global Gene and Cell Therapy Market Segmentation - By Vector, By Application
5.1 Competitive Scenario of Global Gene and Cell Therapy Market: By Vector
5.1.1 Lentivirus - Market Size and Forecast (2016-2026)
5.1.2 AAV - Market Size and Forecast (2016-2026)
5.1.3 Retrovirus & Gammaretrovirus - Market Size and Forecast (2016-2026)
5.1.4 Others - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Gene and Cell Therapy Market: By Application
5.2.1 Oncology - Market Size and Forecast (2016-2026)
5.2.2 Neurological Disorders - Market Size and Forecast (2016-2026)
5.2.3 cardiovascular disorders - Market Size and Forecast (2016-2026)
5.2.4 Others - Market Size and Forecast (2016-2026)
6. Global Gene and Cell Therapy Market: Regional Analysis
6.1 Competitive Scenario of Global Gene and Cell Therapy Market : By Region
7. North America Gene and Cell Therapy Market: An Analysis (2016-2026)
7.1 North America Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
7.2 North America Gene and Cell Therapy Market - Prominent Companies
7.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus, Others)
7.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others) 7.5 North America Gene and Cell Therapy Market: Country Analysis
7.6 Market Opportunity Chart of North America Gene and Cell Therapy Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Gene and Cell Therapy Market: By Country
7.8 United States Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
7.9 United States Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
7.10 Canada Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
7.11 Canada Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8. Europe Gene and Cell Therapy Market: An Analysis (2016-2026)
8.1 Europe Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.2 Europe Gene and Cell Therapy Market - Prominent Companies
8.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus, Others)
8.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders and Others)
8.5 Europe Gene and Cell Therapy Market: Country Analysis
8.6 Market Opportunity Chart of Europe Gene and Cell Therapy Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Gene and Cell Therapy Market: By Country
8.8 Germany Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.9 Germany Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8.10 United Kingdom Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.11 United Kingdom Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8.12 France Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.13 France Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
8.14 Italy Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
8.15 Italy Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9. Asia Pacific Gene and Cell Therapy Market: An Analysis (2016-2026)
9.1 Asia Pacific Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Gene and Cell Therapy Market - Prominent Companies
9.3 Market Segmentation By Vector (Lentivirus, AAV, Retrovirus & Gammaretrovirus, Others)
9.4 Market Segmentation By Application (Oncology, Neurological Disorders, cardiovascular disorders, Others)
9.5 Asia Pacific Gene and Cell Therapy Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Gene and Cell Therapy Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Gene and Cell Therapy Market: By Country
9.8 China Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.9 China Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9.10 Japan Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.11 Japan Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.12 India Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9.13 India Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
9.14 South Korea Gene and Cell Therapy Market Segmentation - By Vector, By Application (2016-2026)
9.15 South Korea Gene and Cell Therapy Market: Size and Forecast (2016-2026), By Value
10.Global Gene and Cell Therapy Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Gene and Cell Therapy Market - By Vector, 2026
11.2 Market Attractiveness Chart of Global Gene and Cell Therapy Market - Application, 2026
11.3 Market Attractiveness Chart of Global Gene and Cell Therapy Market - By Region, 2026
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Gene Therapy Companies
12.3 Market Share Analysis
13. Company Analysis
13.1 F. Hoffman-La Roche Ltd.
13.2 Novartis
13.3 Sanofi
13.4 Alnylam Pharmaceuticals Inc.
13.5 Pfizer
13.6 BlueBird Inc.
13.7 Sarepta Therapeutics
13.8 Voyager Therapeutics
13.9 Orchard Therapeutics Plc
13.10 AnGes Inc.
List of Figures
Figure 1: Global Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Figure 6: Global Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 7: Global Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 8: Global Gene and Cell Therapy Market- By Vector Market Share, 2020 & 2026
Figure 9: Global Gene and Cell Therapy Market- By Lentivirus, By Value (USD Million), 2016-2026
Figure 10: Global Gene and Cell Therapy Market- By AAV, By Value (USD Million), 2016-2026
Figure 11: Global Gene and Cell Therapy Market- By Retrovirus & Gammaretrovirus, By Value (USD Million), 2016-2026
Figure 12: Global Gene and Cell Therapy Market- By Others, By Value (USD Million), 2016-2026
Figure 13: Global Gene and Cell Therapy Market- By Application Market Share, 2020 & 2026
Figure 14: Global Gene and Cell Therapy Market- By Oncology, By Value (USD Million), 2016-2026
Figure 15: Global Gene and Cell Therapy Market- By Neurological disorders , By Value (USD Million), 2016-2026
Figure 16: Global Gene and Cell Therapy Market- By cardiovascular disorders, By Value (USD Million), 2016-2026
Figure 17: Global Gene and Cell Therapy Market- By Others, By Value (USD Million), 2016-2026
Figure 18: Global Gene and Cell Therapy Market- By Region Market Share, 2020 & 2026
Figure 19: North America Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 20: North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 21: North America Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 22: North America Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 23: North America Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 24: North America Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 25: Market Opportunity Chart of North America Gene and Cell Therapy Market- By Country, By Value (Year-2026)
Figure 26: North America Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
Figure 27: United States Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 28: United State Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 29: United State Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 30: United State Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 31: United State Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 32: United State Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 33: Canada Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 34: Canada Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 35: Canada Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 36: Canada Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 37: Canada Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 38: Canada Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 39: Europe Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 40: Europe Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 41: Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 42: Europe Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 43: Europe Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 44: Europe Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 45: Market Opportunity Chart of Europe Gene and Cell Therapy Market- By Country, By Value (Year-2026)
Figure 46: Europe Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
Figure 47: Germany Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 48: Germany Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 49: Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 50: Germany Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 51: Germany Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 52: Germany Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 53: United Kingdom Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 54: United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 55: United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 56: United Kingdom Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 57: United Kingdom Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 58: United Kingdom Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 59: France Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 60: France Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 61: France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 62: France Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 63: France Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 64: France Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 65: Italy Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Billion)
Figure 66: Italy Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 67: Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 68: Italy Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 69: Italy Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 70: Italy Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 71: Asia Pacific Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 72: Asia Pacific Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 73: Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 74: Asia Pacific Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 75: Asia Pacific Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 76: Asia Pacific Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 77: Market Opportunity Chart of APAC Gene and Cell Therapy Market- By Country, By Value (Year-2026)
Figure 78: APAC Gene and Cell Therapy Market- By Country Market Share, 2020 & 2026
Figure 79: China Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 80: China Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 81: China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 82: China Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 83: China Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 84: China Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 85: Japan Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 86: Japan Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 87: Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 88: Japan Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 89: Japan Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 90: Japan Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 91: India Pharmacy Retail Market Size, By Value, 2016-2026 (USD Billion)
Figure 92: India Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 93: India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 94: India Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 95: India Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 96: India Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 97: South Korea Gene and Cell Therapy Market Size, By Value, 2016-2026 (USD Million)
Figure 98: South Korea Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Figure 99: South Korea Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Figure 100: South Korea Prevalence of Total Cancer, 2015-2019 (In Millions)
Figure 101: South Korea Gene and Cell Therapy Market- By Vector, By Value (USD Million), 2016-2026
Figure 102: South Korea Gene and Cell Therapy Market- By Application, By Value (USD Million), 2016-2026
Figure 103: Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Vector (Year-2026)
Figure 104: Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Application (Year-2026)
Figure 105: Market Attractiveness Chart of Global Gene and Cell Therapy Market- By Region (Year-2026)
Figure 106: Global Gene and Cell Therapy company market share (%), 2020
Figure 107: F. Hoffman-La Roche Ltd. Sales Revenues, 2016-2020 (USD Million)
Figure 108: F. Hoffman-La Roche Ltd. Net Income, 2016-2020 (USD Million)
Figure 109: F. Hoffman-La Roche Ltd. sales Revenues, By Business Segment (%), FY2020
Figure 110: F. Hoffman-La Roche Ltd. sales Revenue, By Geographical Segment (%), FY2020
Figure 111: Novartis Annual Sales Revenue (USD Million), 2016-2020
Figure 112: Novartis Annual Net Income/Loss (USD Million), 2016-2020
Figure 113: Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
Figure 114: Novartis Sales Revenue Split, By Geography Segment (%), FY2020
Figure 115: Sanofi Sales Revenues, 2016-2020 (USD Million)
Figure 116: Sanofi Gross Profit, 2016-2020 (USD Million)
Figure 117: Sanofi Sales Revenue Split, By Business Segment (%), FY2020
Figure 118: Sanofi Sales Revenue Split, By Geography Segment (%), FY2020
Figure 119: Alnylam Pharmaceuticals Inc. Sales Revenues, 2016-2020 (USD Million)
Figure 120: Alnylam Pharmaceuticals Inc. sales Revenues, By Business Segment (%), FY2020
Figure 121: Alnylam Pharmaceuticals Inc. sales Revenue, By Geographical Segment (%), FY2020
Figure 122: Pfizer Annual Sales Revenue (USD Million), 2016-2020
Figure 123: Pfizer Annual Net Income/Loss (USD Million), 2016-2020
Figure 124: Pfizer sales Revenue, By Geographical Segment (%), FY2020
Figure 125: BlueBird Bio Inc. Sales Revenues, 2015-2019 (USD Million)
Figure 126: Sarepta Therapeutics Sales Revenues, 2015-2019 (USD Million)
Figure 127: Voyager Therapeutics Sales Revenues, 2015-2019 (USD Million)
Figure 128: Orchard Therapeutics PLC Sales Revenues, 2018-2020 (USD Million)
Figure 129: AnGes Inc. Sales Revenues, 2015-2019 (USD Million)
Global Gene Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 111
According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period.
The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......
Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)
Published: 01-Jan-2024 Price: US 2450 Onwards Pages: 260
Executive Summary
Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......
Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 88
According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......
Global Gene Expression Analysis Market Status and Outlook 2023-2028
Published: 26-Dec-2023 Price: US 3160 Onwards Pages: 102
Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 125
Market Overview of Global Gene Expression Analysis market:
According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
Global Animal Genetics Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 120
Report Overview:
Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics.
Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......
Global Animal Genetics Market Status and Outlook 2023-2028
Published: 24-Nov-2023 Price: US 3160 Onwards Pages: 105
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Gene Therapy Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 450
Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
